Genzyme
‘Fatal’ safety concerns throw doubt on Lemtrada
November 11, 2013Research and Development, Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi
An FDA committee has dashed hopes of an approval for Sanofi’s multiple sclerosis drug after saying its benefits may not …
NICE: we need more Aubagio data
September 18, 2013Sales and Marketing Aubagio, Genzyme, MS, NICE, Sanofi
Aubagio approved in Europe
September 3, 2013Sales and Marketing Aubagio, Genzyme, Rebif, Sanofi, tecfidera
Sanofi’s once-daily multiple sclerosis pill Aubagio has been authorised by European regulators, paving the way for it to continue its …
Sanofi’s Lemtrada nears EU approval
July 1, 2013Sales and Marketing CHMP, Genzyme, Lemtrada, Sanofi
Sanofi’s multiple sclerosis drug Lemtrada has received a positive recommendation from the CHMP, meaning a European approval is likely just …
Multiple sclerosis rivals gain EU approval
March 27, 2013Research and Development, Sales and Marketing Biogen IDEC, Genzyme, MS
Rival MS treatments from Biogen Idec and Genzyme have both received European approval. The CHMP has recommended marketing authorisation for …
Genzyme’s Waterford plant gets new investment round
February 19, 2013Manufacturing and Production Genzyme, Sanofi, Waterford
Sanofi’s Genzyme unit plans to spend €44 million on upgrading its plant in Waterford, Ireland, to help meet demand for …
CHMP turns down Kynamro
December 17, 2012Sales and Marketing CHMP, Genzyme, Kynamro, Sanofi
Genzyme has expressed frustration at the CHMP’s negative opinion of its novel drug Kynamro, and plans to ask it to …
Genzyme appoints new GM for UK and Ireland
November 29, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brendan Martin, Genzyme
Genzyme has announced the appointment of Brendan Martin as general manager for UK and Ireland. Martin will be responsible for …
FDA committee recommends Kynamro
October 23, 2012Research and Development, Sales and Marketing FDA, Genzyme, Kynamro, Sanofi
Sanofi’s anti-cholestrol drug Kynamro has been recommended by an FDA committee, paving the way for US approval early next year. …
Genzyme MS drug approved in US
September 13, 2012Medical Communications Aubagio, Genzyme, Rebif, Sanofi, Tysabri, gilenya, multiple sclerosis
US regulators have given the green light for Genzyme’s Aubagio to treat patients with relapsing forms of multiple sclerosis (MS). …
Genzyme recalls drug on failed stability testing
September 4, 2012Manufacturing and Production Genzyme, Stability Testing, pharma recalls
Sanofi subsidiary Genzyme has recalled nine lots of its transplant drug Thymoglobulin in the US after stability testing revealed there …
Genzyme ‘confident’ of FDA nod for MS drug
August 29, 2012Sales and Marketing Genzyme, Lemtrada, MS, multiple sclerosis
Genzyme insists it is on course to resubmit an existing oncology drug for the treatment of relapsing multiple sclerosis (RMS), …
More job cuts planned at Sanofi, says union
July 6, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Viehbacher, cuts
Sanofi has confirmed that it is considering a restructuring of its operations in France, but has refused to comment on …
Steve Bates appointed chief executive of the BioIndustry Association
June 25, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Genzyme, Steve Bates
The BioIndustry Association (BIA) has appointed Steve Bates as its chief executive. Bates has worked both in biotech and the …
